BDX News: BCAL Files Foundational Patent Application - 12th May 2022, 2:29am

[annb0t]

New lipid biomarkers central to development of breast cancer diagnostic blood test are coveredPatent application will underpin future global filings securing key features of BCAL’s test

SYDNEY, Australia, May 11, 2022 (GLOBE NEWSWIRE) -- Breast cancer screening and diagnostic company BCAL Diagnostics Limited (ASX:BDX, ‘BCAL’ or the ‘Company’) is pleased to announce the filing of a provisional patent application number 2022901245 at IP Australia covering key lipid biom...

>>> Read more: BCAL Files Foundational Patent Application